Subcutaneous Biologics Market, Global Outlook and Forecast 2023-2028

Report ID: 1134568 | Published Date: Jan 2025 | No. of Page: 63 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Subcutaneous Biologics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Subcutaneous Biologics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Subcutaneous Biologics Overall Market Size
    2.1 Global Subcutaneous Biologics Market Size: 2021 VS 2028
    2.2 Global Subcutaneous Biologics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Subcutaneous Biologics Players in Global Market
    3.2 Top Global Subcutaneous Biologics Companies Ranked by Revenue
    3.3 Global Subcutaneous Biologics Revenue by Companies
    3.4 Top 3 and Top 5 Subcutaneous Biologics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Subcutaneous Biologics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Subcutaneous Biologics Players in Global Market
        3.6.1 List of Global Tier 1 Subcutaneous Biologics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Subcutaneous Biologics Market Size Markets, 2021 & 2028
        4.1.2 Syringe
        4.1.3 Wearable injector
        4.1.4 Automatic injector
        4.1.5 Implants
    4.2 By Type - Global Subcutaneous Biologics Revenue & Forecasts
        4.2.1 By Type - Global Subcutaneous Biologics Revenue, 2017-2022
        4.2.2 By Type - Global Subcutaneous Biologics Revenue, 2023-2028
        4.2.3 By Type - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Subcutaneous Biologics Market Size, 2021 & 2028
        5.1.2 Hospital pharmacies
        5.1.3 Retail pharmacies
        5.1.4 Drug stores
        5.1.5 Online pharmacies
    5.2 By Application - Global Subcutaneous Biologics Revenue & Forecasts
        5.2.1 By Application - Global Subcutaneous Biologics Revenue, 2017-2022
        5.2.2 By Application - Global Subcutaneous Biologics Revenue, 2023-2028
        5.2.3 By Application - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Subcutaneous Biologics Market Size, 2021 & 2028
    6.2 By Region - Global Subcutaneous Biologics Revenue & Forecasts
        6.2.1 By Region - Global Subcutaneous Biologics Revenue, 2017-2022
        6.2.2 By Region - Global Subcutaneous Biologics Revenue, 2023-2028
        6.2.3 By Region - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Subcutaneous Biologics Revenue, 2017-2028
        6.3.2 US Subcutaneous Biologics Market Size, 2017-2028
        6.3.3 Canada Subcutaneous Biologics Market Size, 2017-2028
        6.3.4 Mexico Subcutaneous Biologics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Subcutaneous Biologics Revenue, 2017-2028
        6.4.2 Germany Subcutaneous Biologics Market Size, 2017-2028
        6.4.3 France Subcutaneous Biologics Market Size, 2017-2028
        6.4.4 U.K. Subcutaneous Biologics Market Size, 2017-2028
        6.4.5 Italy Subcutaneous Biologics Market Size, 2017-2028
        6.4.6 Russia Subcutaneous Biologics Market Size, 2017-2028
        6.4.7 Nordic Countries Subcutaneous Biologics Market Size, 2017-2028
        6.4.8 Benelux Subcutaneous Biologics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Subcutaneous Biologics Revenue, 2017-2028
        6.5.2 China Subcutaneous Biologics Market Size, 2017-2028
        6.5.3 Japan Subcutaneous Biologics Market Size, 2017-2028
        6.5.4 South Korea Subcutaneous Biologics Market Size, 2017-2028
        6.5.5 Southeast Asia Subcutaneous Biologics Market Size, 2017-2028
        6.5.6 India Subcutaneous Biologics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Subcutaneous Biologics Revenue, 2017-2028
        6.6.2 Brazil Subcutaneous Biologics Market Size, 2017-2028
        6.6.3 Argentina Subcutaneous Biologics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Subcutaneous Biologics Revenue, 2017-2028
        6.7.2 Turkey Subcutaneous Biologics Market Size, 2017-2028
        6.7.3 Israel Subcutaneous Biologics Market Size, 2017-2028
        6.7.4 Saudi Arabia Subcutaneous Biologics Market Size, 2017-2028
        6.7.5 UAE Subcutaneous Biologics Market Size, 2017-2028
7 Players Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Corporate Summary
        7.1.2 Abbott Laboratories Business Overview
        7.1.3 Abbott Laboratories Subcutaneous Biologics Major Product Offerings
        7.1.4 Abbott Laboratories Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.1.5 Abbott Laboratories Key News
    7.2 Pfizer Inc.
        7.2.1 Pfizer Inc. Corporate Summary
        7.2.2 Pfizer Inc. Business Overview
        7.2.3 Pfizer Inc. Subcutaneous Biologics Major Product Offerings
        7.2.4 Pfizer Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.2.5 Pfizer Inc. Key News
    7.3 Genentech Inc.
        7.3.1 Genentech Inc. Corporate Summary
        7.3.2 Genentech Inc. Business Overview
        7.3.3 Genentech Inc. Subcutaneous Biologics Major Product Offerings
        7.3.4 Genentech Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.3.5 Genentech Inc. Key News
    7.4 Novartis AG
        7.4.1 Novartis AG Corporate Summary
        7.4.2 Novartis AG Business Overview
        7.4.3 Novartis AG Subcutaneous Biologics Major Product Offerings
        7.4.4 Novartis AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.4.5 Novartis AG Key News
    7.5 Biogen Idec
        7.5.1 Biogen Idec Corporate Summary
        7.5.2 Biogen Idec Business Overview
        7.5.3 Biogen Idec Subcutaneous Biologics Major Product Offerings
        7.5.4 Biogen Idec Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.5.5 Biogen Idec Key News
    7.6 AbbVie Inc.
        7.6.1 AbbVie Inc. Corporate Summary
        7.6.2 AbbVie Inc. Business Overview
        7.6.3 AbbVie Inc. Subcutaneous Biologics Major Product Offerings
        7.6.4 AbbVie Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.6.5 AbbVie Inc. Key News
    7.7 F. Hoffmann-La Roche AG
        7.7.1 F. Hoffmann-La Roche AG Corporate Summary
        7.7.2 F. Hoffmann-La Roche AG Business Overview
        7.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Major Product Offerings
        7.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.7.5 F. Hoffmann-La Roche AG Key News
    7.8 Bristol-Myers Squibb
        7.8.1 Bristol-Myers Squibb Corporate Summary
        7.8.2 Bristol-Myers Squibb Business Overview
        7.8.3 Bristol-Myers Squibb Subcutaneous Biologics Major Product Offerings
        7.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.8.5 Bristol-Myers Squibb Key News
    7.9 Eisai Inc.
        7.9.1 Eisai Inc. Corporate Summary
        7.9.2 Eisai Inc. Business Overview
        7.9.3 Eisai Inc. Subcutaneous Biologics Major Product Offerings
        7.9.4 Eisai Inc. Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.9.5 Eisai Inc. Key News
    7.10 Takeda Pharmaceuticals Ltd.
        7.10.1 Takeda Pharmaceuticals Ltd. Corporate Summary
        7.10.2 Takeda Pharmaceuticals Ltd. Business Overview
        7.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Major Product Offerings
        7.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.10.5 Takeda Pharmaceuticals Ltd. Key News
    7.11 Alnylam Pharmaceuticals
        7.11.1 Alnylam Pharmaceuticals Corporate Summary
        7.11.2 Alnylam Pharmaceuticals Business Overview
        7.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Major Product Offerings
        7.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.11.5 Alnylam Pharmaceuticals Key News
    7.12 Bayer AG
        7.12.1 Bayer AG Corporate Summary
        7.12.2 Bayer AG Business Overview
        7.12.3 Bayer AG Subcutaneous Biologics Major Product Offerings
        7.12.4 Bayer AG Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.12.5 Bayer AG Key News
    7.13 GlaxoSmithKline
        7.13.1 GlaxoSmithKline Corporate Summary
        7.13.2 GlaxoSmithKline Business Overview
        7.13.3 GlaxoSmithKline Subcutaneous Biologics Major Product Offerings
        7.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue in Global Market (2017-2022)
        7.13.5 GlaxoSmithKline Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Subcutaneous Biologics Market Opportunities & Trends in Global Market
    Table 2. Subcutaneous Biologics Market Drivers in Global Market
    Table 3. Subcutaneous Biologics Market Restraints in Global Market
    Table 4. Key Players of Subcutaneous Biologics in Global Market
    Table 5. Top Subcutaneous Biologics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Subcutaneous Biologics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Subcutaneous Biologics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Subcutaneous Biologics Product Type
    Table 9. List of Global Tier 1 Subcutaneous Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Subcutaneous Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Subcutaneous Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Subcutaneous Biologics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Subcutaneous Biologics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Subcutaneous Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Subcutaneous Biologics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Subcutaneous Biologics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Subcutaneous Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Subcutaneous Biologics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Subcutaneous Biologics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Subcutaneous Biologics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Subcutaneous Biologics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Subcutaneous Biologics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Subcutaneous Biologics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Subcutaneous Biologics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Subcutaneous Biologics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Subcutaneous Biologics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Subcutaneous Biologics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Subcutaneous Biologics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Subcutaneous Biologics Revenue, (US$, Mn), 2023-2028
    Table 30. Abbott Laboratories Corporate Summary
    Table 31. Abbott Laboratories Subcutaneous Biologics Product Offerings
    Table 32. Abbott Laboratories Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 33. Pfizer Inc. Corporate Summary
    Table 34. Pfizer Inc. Subcutaneous Biologics Product Offerings
    Table 35. Pfizer Inc. Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 36. Genentech Inc. Corporate Summary
    Table 37. Genentech Inc. Subcutaneous Biologics Product Offerings
    Table 38. Genentech Inc. Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis AG Corporate Summary
    Table 40. Novartis AG Subcutaneous Biologics Product Offerings
    Table 41. Novartis AG Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 42. Biogen Idec Corporate Summary
    Table 43. Biogen Idec Subcutaneous Biologics Product Offerings
    Table 44. Biogen Idec Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 45. AbbVie Inc. Corporate Summary
    Table 46. AbbVie Inc. Subcutaneous Biologics Product Offerings
    Table 47. AbbVie Inc. Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 48. F. Hoffmann-La Roche AG Corporate Summary
    Table 49. F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offerings
    Table 50. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 51. Bristol-Myers Squibb Corporate Summary
    Table 52. Bristol-Myers Squibb Subcutaneous Biologics Product Offerings
    Table 53. Bristol-Myers Squibb Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 54. Eisai Inc. Corporate Summary
    Table 55. Eisai Inc. Subcutaneous Biologics Product Offerings
    Table 56. Eisai Inc. Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 57. Takeda Pharmaceuticals Ltd. Corporate Summary
    Table 58. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offerings
    Table 59. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 60. Alnylam Pharmaceuticals Corporate Summary
    Table 61. Alnylam Pharmaceuticals Subcutaneous Biologics Product Offerings
    Table 62. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 63. Bayer AG Corporate Summary
    Table 64. Bayer AG Subcutaneous Biologics Product Offerings
    Table 65. Bayer AG Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
    Table 66. GlaxoSmithKline Corporate Summary
    Table 67. GlaxoSmithKline Subcutaneous Biologics Product Offerings
    Table 68. GlaxoSmithKline Subcutaneous Biologics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Subcutaneous Biologics Segment by Type in 2021
    Figure 2. Subcutaneous Biologics Segment by Application in 2021
    Figure 3. Global Subcutaneous Biologics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Subcutaneous Biologics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Subcutaneous Biologics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2021
    Figure 8. By Type - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 12. US Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 16. Germany Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 24. China Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 30. Brazil Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Subcutaneous Biologics Revenue Market Share, 2017-2028
    Figure 33. Turkey Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Subcutaneous Biologics Revenue, (US$, Mn), 2017-2028
    Figure 37. Abbott Laboratories Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pfizer Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Genentech Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Biogen Idec Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. AbbVie Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Bristol-Myers Squibb Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Eisai Inc. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Bayer AG Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. GlaxoSmithKline Subcutaneous Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
63
Frequently Asked Questions
Subcutaneous Biologics Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Subcutaneous Biologics Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Subcutaneous Biologics Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports